背景:德国医院在法律上有义务在未来几年内实施数字患者门户。系统评价表明,患者门户的使用可能与改善的以患者为中心和工作流程有关。然而,强制性数字医疗创新有时没有被目标群体按计划使用,甚至完全拒绝。基于罗杰的创新扩散理论,可以假设时间因素对于患者入口的采用特别重要.该项目的目的是评估患者门户采用的决定因素,并检查Roger的理论是否可以得到证实。
方法:该项目使用具有三个横截面时间点的纵向研究设计,在德国一家大型学术教学医院的三个不同诊所中调查了患者门户的使用(预,post,post).对医生和患者进行了有关预测患者门户使用的因素以及这些因素的强度是否随时间变化的调查。还采访了他们在使用患者门户时可能遇到的障碍或不使用患者门户的原因。回归模型和内容分析用于回答研究问题。
结论:将根据Roger理论的时间成分讨论患者门户使用的决定因素。同时,预计随着时间的推移,一些决定因素将保持不变。确定独立于时间的决定因素允许针对群体,启用特定的沟通策略,使这些群体能够使用患者门户,为平等的医疗保健系统做出贡献。
背景:该研究于2024年5月在德国临床试验注册(DRKS00033125)中进行了前瞻性注册。
BACKGROUND: German hospitals are legally obliged to implement digital patient portals within the next years. Systematic reviews show that the use of patient portals may be associated with improved patient-centeredness and workflows. However, mandatory digital healthcare innovations are sometimes not used by the target group as planned or even completely rejected. Based on Roger\'s theory of innovation diffusion, it can be assumed that the time factor is of particular importance for the adoption of the patient portal. The aim of the project is to assess determinants of patient portal adoption and to examine whether Roger\'s theory can be confirmed.
METHODS: The project investigates the use of the patient portal in three different clinics of a large academic teaching hospital in Germany using a longitudinal study design with three cross-sectional time points (pre, post, post). Doctors and patients are surveyed about factors that predict the use of the patient portal and whether the strength of these factors changes over time. They are also interviewed about possible barriers they experience when using the patient portal or about the reasons why the patient portal is not used. Regression models and content analyses are used to answer the research questions.
CONCLUSIONS: Determinants of patient portal use will be discussed under the light of the temporal component of Roger\'s theory. At the same time, it is expected that some determinants will remain unchanged over time. Identifying determinants independent of time allows targeting the groups, enabling specific communication strategies to empower these groups to use the patient portal, contributing to an equal health care system.
BACKGROUND: The study was prospectively registered in the German register of clinical trials (DRKS00033125) in May 2024.